Published in Drug Week, May 20th, 2011
"Many peptides have a short half-life, in vivo half-life, and insufficient oral availability. Inspired by the N-methylation of peptides as a promising way to rationally improve key pharmacokinetic characteristics, we report our efforts toward an easy synthesis of new monomers N-beta-Fmoc-N-beta-Me-aza-beta(3)-amino acids," wrote I. Nicolas and colleagues, University of Rennes.
The researchers concluded: "These synthetic building blocks will be useful for solid-phase synthesis of new...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.